Clinical Trial Update: SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reporting PK/PD profiles for SS109 and NovoSeven on-demand use, with preliminary efficacy and safety data in patients with hemop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)
• SS109

Snippet

Sponsor: Jiangsu Gensciences lnc. | Conditions: Male, Hemophilia A With Inhibitor | Phase 1, Phase 2 | Status: COMPLETED